Quanterix Corporation (QTRX)

15.90 -0.14 (-0.87%) As of 01:04PM EDT. Market open.

Quanterix Corporation

Building 1
900 Middlesex Turnpike
Billerica, MA 01821
United States
617-301-9400
https://www.quanterix.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 441

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Masoud Toloue Ph.D.	President, CEO & Director	1.44M	N/A	1981
Dr. David R. Walt Ph.D.	Co-Founder, Chairman of Scientific Advisory Board & Independent Director	47.25k	N/A	1953
Mr. Daniel Pikora	Chief Operating Officer	N/A	N/A	1976
Dr. David C. Duffy Ph.D.	Senior VP of Research & Development and CTO	299.05k	N/A	1971
Ms. Alexandra Phillips	Senior VP & Chief Information Officer	N/A	N/A	N/A
Ms. Laurie A. Churchill	Senior VP, General Counsel & Secretary	N/A	N/A	1971
Mr. Naren Bhat	Senior Vice President of Corporate Development & Strategy	N/A	N/A	N/A
Ms. Erica Bell	Chief People Officer	N/A	N/A	1973
Dr. Mark T. Roskey Ph.D.	Senior Vice President of Strategic Partnerships	495.03k	845.13k	1960
Ms. Mary Ellen Cortizas	VP of Laboratory Services & CRO	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

Corporate governance

Quanterix Corporation’s ISS governance QualityScore as of 1 April 2024 is 9. The pillar scores are Audit: 9; Board: 10; Shareholder rights: 8; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.